z-logo
open-access-imgOpen Access
STANDARDIZATION OF NASYA DOSE BY BINDU PRAMANA WITH KARPASASTYADI TAILA
Author(s) -
Sreeja. V. S,
Vikram Kumar
Publication year - 2021
Publication title -
international ayurvedic medical journal
Language(s) - English
Resource type - Journals
ISSN - 2320-5091
DOI - 10.46607/iamj0709062021
Subject(s) - standardization , medicine , family medicine , medical physics , computer science , operating system
Panchakarma therapy has a very important role in maintaining health of a person and eradication of diseases. The success with Panchakarma therapies can be achieved not only through correct assessment of the patient and the medicines used but also the dose of the medicine. Dose for this therapy is very specific and is explained in the classics on the basis of Bindu Pramana. Dose is a very important factor in any of the Panchakarma procedures to get optimum result of the therapy. Change in dose can change the result and further, it can lead to side effects or no effects. However, standardization of this dose had not been made yet. This paper deals with classical concept of Bindu Pramana, preparation, and standardization of Karpasastyadi Taila in Bindu Pramana Matra. The objective is to standardize the process of measurement of Bindu Pramana Matra of Karpasastyadi Taila. Healthy 60 individuals consisting of staffs and students of Alvas Ayurveda Medical College of either gender aged between 20 years to 60 years were selected and purposively assigned into study group. Results were observed and tabulation of data with a statistical commentary based on percentages of different observations was made. Study shows variation in quantity of Madhyama Bindu Pramana Matra and differs from patient to patient. Bindu Pramana varies from subject to subject. Analysis of the results showed that Bindu is not equivalent to drop.Keywords: Panchakarma; Nasya Karma; Karpasastyadi Taila; Bindu Pramana

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here